AtriCure (NASDAQ: ATRC) reported Q2 EPS of $0.18, $0.19 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $153.6 million versus the consensus estimate of $151.84 million.

GUIDANCE:

AtriCure sees FY2026 EPS of $0.24-$0.32, versus the consensus of $0.12.

For earnings history and earnings-related data on AtriCure (ATRC) click here.